• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用阿坎酸治疗酒精依赖门诊患者:一项临床综述。

Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.

作者信息

Mason B J

机构信息

Department of Psychiatry and Behavioral Sciences, University of Miami/JMH Medical Center, Fla 33136, USA.

出版信息

J Clin Psychiatry. 2001;62 Suppl 20:42-8.

PMID:11584875
Abstract

Acamprosate (calcium acetyl-homotaurine) is a synthetic compound whose chemical structure resembles that of homotaurine, a naturally occurring amino acid. Acamprosate acts centrally and appears to restore the normal activity of glutaminergic neurons, which become hyperexcited as a result of chronic alcohol exposure. Although not yet approved for use in the United States, acamprosate has been available by prescription in France since 1989 and is now available in many other countries throughout the world. This article reviews data from all published double-blind, placebo-controlled clinical trials of acamprosate among alcohol-dependent outpatients. Overall, patients treated with acamprosate exhibited a significantly greater rate of treatment completion, time to first drink, abstinence rate, and/or cumulative abstinence duration than patients treated with placebo. The drug's reliable effect on prolonging abstinence, in conjunction with an excellent safety profile, suggests that acamprosate may be useful for a broad range of patients with alcohol dependence.

摘要

阿坎酸(钙乙酰高牛磺酸)是一种合成化合物,其化学结构类似于天然存在的氨基酸高牛磺酸。阿坎酸作用于中枢,似乎能恢复因长期接触酒精而变得过度兴奋的谷氨酰胺能神经元的正常活性。尽管阿坎酸尚未在美国获批使用,但自1989年起在法国可凭处方获得,现在在世界上许多其他国家也可获得。本文回顾了所有已发表的、针对酒精依赖门诊患者的阿坎酸双盲、安慰剂对照临床试验数据。总体而言,与接受安慰剂治疗的患者相比,接受阿坎酸治疗的患者在治疗完成率、首次饮酒时间、戒酒率和/或累积戒酒持续时间方面均显著更高。该药物在延长戒酒方面的可靠效果,再加上出色的安全性,表明阿坎酸可能对广泛的酒精依赖患者有用。

相似文献

1
Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.使用阿坎酸治疗酒精依赖门诊患者:一项临床综述。
J Clin Psychiatry. 2001;62 Suppl 20:42-8.
2
Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.双盲、安慰剂对照试验中口服阿坎酸对酒精依赖患者戒酒的影响:患者动机的作用
J Psychiatr Res. 2006 Aug;40(5):383-93. doi: 10.1016/j.jpsychires.2006.02.002. Epub 2006 Mar 20.
3
Acamprosate in the treatment of alcohol dependence.阿坎酸用于治疗酒精依赖。
Expert Opin Pharmacother. 2005 Oct;6(12):2103-15. doi: 10.1517/14656566.6.12.2103.
4
The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.坎普拉酸(乙酰高牛磺酸钙)在治疗酒精依赖中的神经生物学、临床疗效和安全性。
Expert Opin Drug Saf. 2010 Jan;9(1):177-88. doi: 10.1517/14740330903512943.
5
Acamprosate for the treatment of alcohol dependence.阿坎酸用于治疗酒精依赖。
Clin Ther. 2005 Jun;27(6):695-714. doi: 10.1016/j.clinthera.2005.06.015.
6
Acamprosate for the adjunctive treatment of alcohol dependence.阿坎酸用于酒精依赖的辅助治疗。
Ann Pharmacother. 2003 Jul-Aug;37(7-8):1090-9. doi: 10.1345/aph.1C351.
7
Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.在美国家庭医学环境中使用坎普拉酸治疗酒精依赖的疗效:一项随机、双盲、安慰剂对照研究。
Alcohol Clin Exp Res. 2013 Apr;37(4):668-74. doi: 10.1111/acer.12010. Epub 2012 Nov 7.
8
Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.急性酒精戒断期间及之后使用阿坎酸:西班牙一项双盲安慰剂对照研究
Alcohol Alcohol. 2001 Sep-Oct;36(5):413-8. doi: 10.1093/alcalc/36.5.413.
9
Acamprosate: A Review of Its Use in Alcohol Dependence.安非他酮:在酒精依赖中的应用综述。
Drugs. 2015 Jul;75(11):1255-68. doi: 10.1007/s40265-015-0423-9.
10
Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.在德国进行的一项针对酒精中毒的双盲、安慰剂对照药物治疗试验的结果,并与美国 COMBINE 研究进行了比较。
Addict Biol. 2013 Nov;18(6):937-46. doi: 10.1111/adb.12012. Epub 2012 Dec 12.

引用本文的文献

1
'But … Would I Be Able to Toast With Friends?' When Service Users Ask for New Care Pathways.“但是……我还能和朋友们一起举杯庆祝吗?”当服务使用者要求新的护理途径时。
Health Expect. 2024 Oct;27(5):e14148. doi: 10.1111/hex.14148.
2
Sodium acamprosate and calcium exert additive effects on nucleus accumbens dopamine in the rat.纳曲酮和钙对大鼠伏隔核多巴胺有相加作用。
Addict Biol. 2022 Sep;27(5):e13224. doi: 10.1111/adb.13224.
3
Medications for alcohol use disorders: An overview.酒精使用障碍的药物治疗:概述。
Pharmacol Ther. 2018 May;185:64-85. doi: 10.1016/j.pharmthera.2017.11.007. Epub 2017 Dec 2.
4
Use of Anti-Craving Agents in Soldiers with Alcohol Dependence Syndrome.抗渴望药物在酒精依赖综合征士兵中的应用。
Med J Armed Forces India. 2008 Oct;64(4):320-4. doi: 10.1016/S0377-1237(08)80009-3. Epub 2011 Jul 21.
5
A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease.基于拉施模型应用于阿尔茨海默病的多标记基因关联测试
PLoS One. 2015 Sep 17;10(9):e0138223. doi: 10.1371/journal.pone.0138223. eCollection 2015.
6
An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.COMBINE研究中的调节因素分析:识别从阿坎酸中获益的患者亚组。
Eur Neuropsychopharmacol. 2015 Oct;25(10):1586-99. doi: 10.1016/j.euroneuro.2015.06.006. Epub 2015 Jun 20.
7
The pharmacogenetics of alcohol use disorder.酒精使用障碍的药物遗传学
Alcohol Clin Exp Res. 2015 Mar;39(3):391-402. doi: 10.1111/acer.12643. Epub 2015 Feb 19.
8
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.联合使用两种重新利用的药物作为治疗阿尔茨海默病的一种有前景的方法。
Sci Rep. 2015 Jan 8;5:7608. doi: 10.1038/srep07608.
9
The development of acamprosate as a treatment against alcohol relapse.阿坎酸作为防治酒精复吸治疗药物的研发。
Expert Opin Drug Discov. 2014 Nov;9(11):1355-69. doi: 10.1517/17460441.2014.960840. Epub 2014 Sep 26.
10
An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits.一项针对酒精依赖的住院治疗及出院计划方案:在减少30天再入院率和急诊就诊次数方面的疗效。
J Gen Intern Med. 2015 Mar;30(3):365-70. doi: 10.1007/s11606-014-2968-9. Epub 2014 Aug 5.